Is 7-OH Legal in My State?
State-by-State 7-Hydroxymitragynine (7-OH) Legality Guide — Updated October 15, 2026
7-hydroxymitragynine (7-OH) is not yet federally scheduled, but a revised DEA order can take effect on or after November 13, 2026. On October 14, 2026 the DEA withdrew its July notice and published a new notice of intent covering 7-OH and mitragynine pseudoindoxyl above a revised concentration threshold. Three related compounds (mitragynine pseudoindoxyl, MGM-15 and MGM-16) have been temporary Schedule I substances since August 26, 2026.
At the state level, 28 of 51 jurisdictions already restrict 7-OH in some form: 11 prohibit it outright as part of a full kratom ban, California prohibits it through agency action, 2 (Ohio and Rhode Island) ban isolated or synthetic 7-OH while allowing natural leaf, 2 (Florida and Mississippi) set hard numeric limits, and 12 cap it as a percentage of total alkaloids under a Kratom Consumer Protection Act.
The critical distinction: 7-OH rules are frequently not the same as kratom rules. Several states allow natural kratom leaf while banning concentrated or isolated 7-OH, so check both before you buy.
7-hydroxymitragynine — written variously as 7-OH, 7OH, 7-hydroxy, or 7-HMG — is a minor alkaloid found at trace or undetectable levels in dried kratom leaf. Because concentrated and isolated 7-OH products are chemically and legally distinct from leaf powder, states regulate them separately. Use the map below to check your state, then read the federal section, which will apply nationwide regardless of state law.
What is the federal status of 7-OH right now?
Three related compounds are scheduled; the 7-OH order is pending
Already in effect: mitragynine pseudoindoxyl, MGM-15 and MGM-16 have been temporary Schedule I controlled substances since August 26, 2026[2].
Pending for 7-OH: the DEA's original 7-OH notice published July 6, 2026[1] never produced an order. On October 14, 2026, after an October 8 recommendation from HHS, the DEA withdrew it and published a new notice of intent covering 7-OH and mitragynine pseudoindoxyl when either one, or both combined, exceed a specified threshold[7].
The July thresholds (now withdrawn): 0.05% 7-OH for the kratom plant itself, and either 0.05% or 1 milligram of 7-OH for material further processed into other dosage forms — extracts, concentrates, processed edibles, and pressed pills.
What has not happened yet: the October notice is a notice of intent, not an order. The temporary scheduling order can publish no earlier than November 13, 2026, takes effect on its publication date, and lasts two years (extendable by one)[7].
The practical read: traditional botanical kratom leaf carrying naturally occurring trace 7-OH is not the target of this action. The thresholds are written to capture concentrated and semi-synthetic products — the isolate tablets, “enhanced” extracts, and shots that proliferated between 2023 and 2025 — rather than conventional leaf powder.
Because the threshold is concentration-based rather than a flat prohibition, whether any given product qualifies is a laboratory question, not a label question. That makes a current certificate of analysis the only reliable way to know where a product sits. For how 7-OH is measured and what a COA should disclose, see our guide to what 7-OH is and how it is concentrated.
7-OH legality by state: full table
Every jurisdiction below links to its full kratom legality guide. Note that a state can appear as “no state 7-OH law” here while still regulating kratom leaf in other ways.
| Jurisdiction | 7-OH status | Basis and limit |
|---|---|---|
| Alabama | PROHIBITED | Mitragynine and 7-OH are Schedule I controlled substances. |
| Alaska | NO STATE 7-OH LAW | No state 7-OH statute. |
| Arizona | KCPA LIMIT | KCPA in force. 7-OH limited as a share of total alkaloids; synthetic alkaloids barred. |
| Arkansas | PROHIBITED | Mitragynine and 7-OH added to the controlled substances list in 2015. |
| California | PROHIBITED (DE FACTO) | CDPH declared kratom and 7-OH products unlawful to sell or manufacture, effective Oct 24, 2025. |
| Colorado | KCPA LIMIT | SB 25-072 caps 7-OH at 2% of total alkaloids and bans synthetic alkaloids; 21+ under SB 22-120. |
| Connecticut | PROHIBITED | Full kratom ban effective Mar 25, 2026 (HB 6855). No grandfather clause. |
| Delaware | RESTRICTED | 21+ sales age since Sep 8, 2026 (HS 1 for HB 332). No 7-OH concentration limit. |
| District of Columbia | PROHIBITED | Kratom products, including 7-OH, are not lawfully sold in the District. |
| Florida | NUMERIC LIMIT | Emergency rule signed Jun 22, 2026: 7-OH and six related compounds capped at 1 mg per gram or mL, AND mitragynine must be at least 100x the 7-OH mass. |
| Georgia | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| Hawaii | NO STATE 7-OH LAW | No state 7-OH statute. |
| Idaho | RESTRICTED | Restrictions apply; no 7-OH-specific concentration limit. |
| Illinois | RESTRICTED | Age and local restrictions; no statewide 7-OH concentration limit. |
| Indiana | PROHIBITED | Mitragynine and 7-OH are listed as synthetic drugs (Ind. Code 35-31.5-2-321). |
| Iowa | NO STATE 7-OH LAW | No state 7-OH statute. |
| Kansas | PROHIBITED | Full ban effective Jul 1, 2026 (HB 2365). Schedules 7-OH with no concentration threshold. |
| Kentucky | KCPA LIMIT | KCPA limit applies now. A full ban takes effect Jan 1, 2027 (HB 757 override). |
| Louisiana | PROHIBITED | Full kratom ban effective Aug 1, 2025. |
| Maine | NO STATE 7-OH LAW | No state 7-OH statute. |
| Maryland | RESTRICTED | HB 1523 (Ch. 354, effective Jul 1, 2026): kratom with excessive 7-OH, synthetic alkaloids or no alkaloid disclosure may not be sold. No published numeric 7-OH cap. |
| Massachusetts | NO STATE 7-OH LAW | No state 7-OH statute. |
| Michigan | RESTRICTED | Kratom remains legal. HB 5537 passed the House in Mar 2026 but is not law. |
| Minnesota | RESTRICTED | 21+ purchase and possession age (HF 3453, effective Aug 1, 2026). No 7-OH concentration limit. |
| Mississippi | NUMERIC LIMIT | Strictest cap in the country: 7-OH must be under 1% of total alkaloids AND under 0.5 mg per container. Per-SKU registration required. |
| Missouri | NO STATE 7-OH LAW | No state 7-OH statute. Kansas City bans 7-OH, and Attorney General settlements halted several distributors' 7-OH sales in 2026. |
| Montana | NO STATE 7-OH LAW | No state 7-OH statute. |
| Nebraska | NO STATE 7-OH LAW | No state 7-OH statute. |
| Nevada | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| New Hampshire | NO STATE 7-OH LAW | Legal at 18+; no 7-OH concentration limit. |
| New Jersey | NO STATE 7-OH LAW | No state 7-OH statute. S301, which would place 7-OH in Schedule I, is pending. |
| New Mexico | NO STATE 7-OH LAW | No state 7-OH statute. |
| New York | RESTRICTED | Legal at 21+. A 7-OH sales ban (S8925A: over 2% of alkaloids or 1 mg per serving) passed the Legislature in June 2026 and awaits the Governor. |
| North Carolina | NO STATE 7-OH LAW | Legal at 18+; no 7-OH concentration limit. |
| North Dakota | PROHIBITED | HB 1628 (signed Sep 4, 2026) bans 7-OH, mitragynine pseudoindoxyl, MGM-15 and MGM-16. No kratom may be sold until licensing rules take effect (expected 2027); licensed natural leaf will be capped at 0.05% 7-OH by dry weight. |
| Ohio | ISOLATES BANNED | OAC 4729:9-1-01.1 (effective May 19, 2026) schedules mitragynine-related compounds and exempts only natural leaf and ground leaf, so 7-OH, extracts, shots and gummies are banned. Ohio has no KCPA. |
| Oklahoma | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| Oregon | RESTRICTED | Oregon Kratom Consumer Protection Act (HB 4010, 2022): processor registration and 21+. No 7-OH concentration limit. |
| Pennsylvania | NO STATE 7-OH LAW | No state 7-OH concentration statute. |
| Rhode Island | ISOLATES BANNED | Rhode Island Kratom Act prohibits synthetic 7-OH. First state to reverse a prior kratom ban. Retailer licensing and testing required. |
| South Carolina | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| South Dakota | NO STATE 7-OH LAW | No state 7-OH statute. |
| Tennessee | PROHIBITED | Full ban effective Jul 1, 2026 (HB 1649). Includes natural leaf. |
| Texas | KCPA LIMIT | KCPA in force. Active AG enforcement against non-compliant out-of-state shippers. |
| Utah | KCPA LIMIT | KCPA in force. Annual per-product registration with the Dept. of Agriculture. |
| Vermont | PROHIBITED | Mitragynine and 7-OH are regulated drugs; sale and possession prohibited. |
| Virginia | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| Washington | NO STATE 7-OH LAW | No state 7-OH statute. Mount Vernon and Bellingham ban kratom and 7-OH sales. |
| West Virginia | KCPA LIMIT | KCPA in force. 7-OH capped as a share of total alkaloids. |
| Wisconsin | PROHIBITED | Mitragynine and 7-OH are Schedule I controlled substances. |
| Wyoming | KCPA LIMIT | KCPA (SF0056) in force Jul 1, 2026, with 21+ age and potency limits. |
Why 7-OH rules differ from kratom leaf rules
7-OH is a minor alkaloid. In dried kratom leaf it sits at trace or undetectable levels, and much of what is present forms through oxidation of mitragynine after harvest rather than through the plant's own biosynthesis. Concentrated and isolated 7-OH products are therefore a different category of product from leaf powder, both chemically and legally. Legislatures have responded in four broad patterns, which is why no single national answer exists.
1. Full prohibition
A group of states schedule mitragynine and 7-OH together as controlled substances. In these jurisdictions there is no lawful kratom product of any kind, concentrated or not.
2. Isolate-and-synthetic bans
Ohio and Rhode Island allow natural leaf but specifically prohibit isolated or synthetic 7-OH. This is the fastest-growing regulatory model because it targets concentrated products without banning the botanical.
3. Hard numeric caps
Florida and Mississippi set explicit numbers. Mississippi is the strictest in the country, requiring 7-OH under 1% of total alkaloids and under 0.5 mg per container. Florida's June 2026 emergency rule imposes a dual test: no more than 1 mg per gram or millilitre, and mitragynine must be present at at least 100 times the mass of the 7-OH. That ratio requirement is what makes isolate and super-concentrate formulations unlawful there even when the absolute number looks small.
4. KCPA percentage limits
Kratom Consumer Protection Act states cap 7-OH as a share of total alkaloids and prohibit adulterating kratom with synthetic alkaloids. The specific ceiling varies by state and has been amended repeatedly, so treat the percentage as something to verify rather than assume.
Frequently asked questions about 7-OH legality
Not federally, as of October 15, 2026. The DEA's July 2026 notice never produced an order and was withdrawn on October 14, 2026, when the DEA published a revised notice of intent. That order can publish on or after November 13, 2026 and takes effect the day it publishes. Three related compounds (mitragynine pseudoindoxyl, MGM-15 and MGM-16) are already temporary Schedule I substances as of August 26, 2026. Many states, however, already restrict or prohibit 7-OH under their own laws.
Under the DEA's October 14, 2026 notice, the federal temporary scheduling order can publish in the Federal Register on or after November 13, 2026, and it becomes effective on its publication date rather than after a waiting period. Once effective it remains in place for two years, during which the DEA may pursue permanent scheduling. State bans have their own separate effective dates, several of which have already passed.
15 jurisdictions currently have no 7-OH-specific state statute, and a further 8 impose restrictions without setting a 7-OH concentration limit. But “no state law” is not the same as “legal” once the federal order publishes, because federal scheduling applies nationwide. Use the table above for your specific state, and remember that the federal threshold will govern everywhere.
Not in concentrated form. Since July 1, 2026, Maryland's HB 1523 (Chapter 354) bars retailers from selling noncompliant kratom, and the Alcohol, Tobacco and Cannabis Commission treats products with excessive 7-OH, synthetic alkaloids or no alkaloid disclosure as prohibited. Maryland has no published numeric 7-OH cap, and the pending federal scheduling will also apply there. See our Maryland kratom legality guide for the full picture.
No, not in isolated or synthetic form. Ohio scheduled synthetic and isolated 7-OH under OAC 4729:9-1-01.1, effective May 19, 2026[5]. The rule exempts only mitragynine in vegetation form, so natural leaf and ground leaf are legal, while extracts, shots and gummies are not. Ohio has no Kratom Consumer Protection Act. It is the clearest example of a state where the leaf answer and the 7-OH answer differ.
No. The DEA's 7-OH notices are written around concentration thresholds rather than a flat botanical prohibition, and traditional leaf carrying naturally occurring trace 7-OH is not the focus of the action. The thresholds are aimed at concentrated and semi-synthetic products such as isolate tablets and enhanced extracts.
Because until the federal 7-OH order publishes, 7-OH itself is not federally scheduled, and a vendor can technically make that claim in a state with no 7-OH statute. It is misleading in two ways: it obscures that concentrated 7-OH is pharmacologically distinct from leaf, and it ignores the many states that already restrict it. We do not sell isolated 7-OH products. For the reasoning, see our 7-OH guide.
Read the alkaloid panel on a current, lot-matched certificate of analysis. It should report both mitragynine and 7-OH, letting you calculate 7-OH as a share of total alkaloids and as an absolute amount per gram or per unit. Front-label marketing language is not a substitute. Our COA hub publishes third-party lab results by lot.
Related guides
Lab-Tested Kratom Leaf — No Isolates, Ever
Amazing Botanicals sells natural kratom leaf powder, capsules, and extracts with a third-party alkaloid panel on every lot. We have never sold isolated 7-OH products.
Shop All KratomReferences
- Drug Enforcement Administration. Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I. Federal Register. July 6, 2026. Federal Register
- Drug Enforcement Administration. Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I. Federal Register. July 6, 2026. Federal Register
- Drug Enforcement Administration. DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety. Press release, July 1, 2026. DEA.gov
- Congressional Research Service. Temporary Control of 7-Hydroxymitragynine (7-OH) and Related Substances Under the Controlled Substances Act. LSB11457. Congress.gov
- Ohio Administrative Code 4729:9-1-01.1. Ohio Board of Pharmacy. Effective May 19, 2026.
- Rhode Island General Laws §21-28.13 (Rhode Island Kratom Act). Effective April 1, 2026.
- Drug Enforcement Administration. Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I (notice of intent). Federal Register. October 14, 2026. Federal Register